Literature DB >> 10485263

A rapid method to separate endosomes from lysosomal contents using differential centrifugation and hypotonic lysis of lysosomes.

C J Schröter1, M Braun, J Englert, H Beck, H Schmid, H Kalbacher.   

Abstract

Here we describe a fast and efficient subcellular fractionation procedure that permits lysosomes to be separated from endosomes. Differential centrifugation is used to isolate a subcellular fraction containing both endosomes and lysosomes. Because lysosomes are sensitive to osmotic stress, hypotonic conditions destroy them, whereas endosomes, which are osmotically insensitive, stay intact. We demonstrate that hypotonic lysis of an endosome-lysosome-pool releases 85% of the lysosomes into the supernatant as measured by the activity of the lysosomal marker enzyme N-acetyl-beta-D-glucosaminidase (beta-AGA). The endosomal fraction is thoroughly characterised using a variety of subcellular markers. After pulsing cells with fluorescein isothiocyanate labelled transferrin (FITC-Tf), only about 12% of the marker is released under hypotonic conditions. A typical fractionation procedure takes about 1-2 h from initial cell homogenisation. The fractionation gives a pure lysosomal fraction (fraction L) containing high activities of lysosomal enzymes and an endosomal fraction (fraction E) reflecting different stages of endosomes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485263     DOI: 10.1016/s0022-1759(99)00079-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  24 in total

1.  Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.

Authors:  Ximei Sun; Giuseppe Stefanetti; Francesco Berti; Dennis L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-03       Impact factor: 11.205

Review 2.  Lysosomal membrane proteomics and biogenesis of lysosomes.

Authors:  Richard D Bagshaw; Don J Mahuran; John W Callahan
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

3.  Autophagy promotes MHC class II presentation of peptides from intracellular source proteins.

Authors:  Jörn Dengjel; Oliver Schoor; Rainer Fischer; Michael Reich; Marianne Kraus; Margret Müller; Katharina Kreymborg; Florian Altenberend; Jens Brandenburg; Hubert Kalbacher; Roland Brock; Christoph Driessen; Hans-Georg Rammensee; Stefan Stevanovic
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-13       Impact factor: 11.205

4.  PEG-Benzaldehyde-Hydrazone-Lipid Based PEG-Sheddable pH-Sensitive Liposomes: Abilities for Endosomal Escape and Long Circulation.

Authors:  Manju Kanamala; Brian D Palmer; Hamidreza Ghandehari; William R Wilson; Zimei Wu
Journal:  Pharm Res       Date:  2018-05-31       Impact factor: 4.200

5.  Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate.

Authors:  Nicolas Lützner; Hubert Kalbacher
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

6.  Interaction of human papillomavirus type 16 particles with heparan sulfate and syndecan-1 molecules in the keratinocyte extracellular matrix plays an active role in infection.

Authors:  Zurab Surviladze; Rosa T Sterkand; Michelle A Ozbun
Journal:  J Gen Virol       Date:  2015-08       Impact factor: 3.891

7.  An anti-nucleic acid antibody delivers antigen to the cross-presentation pathway in dendritic cells and potentiates therapeutic antitumor effects.

Authors:  Chuong D Pham; Min-Yeong Woo; Yong-Sung Kim; Sun Park; Myung-Hee Kwon
Journal:  J Immunol       Date:  2012-11-14       Impact factor: 5.422

8.  Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway.

Authors:  Diana Dudziak; Arnd Kieser; Ulrike Dirmeier; Falk Nimmerjahn; Susanne Berchtold; Alexander Steinkasserer; Gabriele Marschall; Wolfgang Hammerschmidt; Gerhard Laux; Georg W Bornkamm
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Quantitative subcellular study of transferrin receptor-targeted doxorubicin and its metabolite in human breast cancer cells.

Authors:  Jinhui Xu; Yuan Sheng; Feifei Xu; Ying Yu; Yun Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-12-22       Impact factor: 2.441

10.  Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing.

Authors:  Peter C Chien; Sandra Cohen; Michael Tuen; James Arthos; Pei-de Chen; Sukeshi Patel; Catarina E Hioe
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.